Effect on Diphtheria Immunity of Combined Tetanus and Diphtheria Booster Vaccination in Adults

被引:0
作者
S. Marlovits
R. Stocker
A. Efstratiou
K. Broughton
A. Kaider
V. Vécsei
H. Kollaritsch
机构
[1] University Clinic for Trauma Surgery,
[2] University of Vienna Medical School,undefined
[3] General Hospital,undefined
[4] Waehringer Guertel 18–20,undefined
[5] 1090 Vienna,undefined
[6] Austria e-mail: stefan.marlovits@akh-wien.ac.at,undefined
[7] WHO Collaborating Centre for Diphtheria and Streptococcal Infections,undefined
[8] PHLS-Respiratory and Systemic Infection Laboratory,undefined
[9] Central Public Health Laboratory,undefined
[10] 61 Colindale Avenue,undefined
[11] London NW9 5HAT,undefined
[12] UK,undefined
[13] Department of Medical Computer Sciences,undefined
[14] University of Vienna,undefined
[15] General Hospital,undefined
[16] Waehringer Guertel 18–20,undefined
[17] 1090 Vienna,undefined
[18] Austria,undefined
[19] Institute for Specific Prophylaxis and Tropical Medicine,undefined
[20] University of Vienna,undefined
[21] Kinderspitalgasse 15,undefined
[22] 1095 Vienna,undefined
[23] Austria,undefined
来源
European Journal of Clinical Microbiology and Infectious Diseases | 2000年 / 19卷
关键词
Tetanus; Diphtheria; Diphtheria Toxin; Booster Vaccination; Full Protection;
D O I
暂无
中图分类号
学科分类号
摘要
 The effect of a single booster injection of an adult formulation of a combined diphtheria–tetanus vaccine (Td) on diphtheria-specific immunity was evaluated. The booster injection, containing 2 IU diphtheria toxoid per dose, was given as part of the surgical wound management for adults with open soft tissue injuries. Diphtheria antitoxin concentrations were determined in serum samples from 534 patients (199 women and 335 men, aged 18–70 years) using an enzyme immunoassay and a tissue culture toxin neutralization assay. Seroimmunity against diphtheria toxin was classified at three levels: susceptibility, basic protection, and full protection against the toxic manifestations of the disease. Before vaccination, 27.1% of the subjects were susceptible to diphtheria, 26.5% had basic protection, and 46.4% were fully protected. Six weeks (minimum 25 days, maximum 98 days) after a single booster injection, 89.7% of the subjects achieved full protection against diphtheria, and only 3.9% had antitoxin levels below the protective level. The median increase from the prevaccination to postvaccination antitoxin concentration was found to be 14-fold (4.4–47; quartiles Q25 to Q75). The change in antitoxin levels after revaccination was higher in older age groups (P<0.001), whereas neither sex (P=0.86) nor the country of previous immunization with a different national immunization schedule (P=0.61) had a significant influence on the revaccination effect. Systemic adverse reactions were rare, and local reactions of clinical significance were reported in only 1.9% of subjects.
引用
收藏
页码:506 / 513
页数:7
相关论文
共 50 条
[41]   Impact of a vaccination campaign on adult immunity to diphtheria [J].
Christenson, B ;
Hellström, U ;
Sylvan, SPE ;
Henriksson, L ;
Granström, M .
VACCINE, 2000, 19 (9-10) :1133-1140
[42]   Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USA [J].
Pool, Vitali ;
Tomovici, Antigona ;
Johnson, David R. ;
Greenberg, David P. ;
Decker, Michael D. .
VACCINE, 2018, 36 (17) :2282-2287
[43]   Factors Influencing Persistence of Diphtheria Immunity and Immune Response to a Booster Dose in Healthy Slovak Adults [J].
Petras, Marek ;
Olear, Vladimir ;
Molitorisova, Milica ;
Danova, Jana ;
Celko, Alexander M. ;
Novakova, Elena ;
Stefkovicova, Maria ;
Kristufkova, Zuzana ;
Malinova, Jana ;
Kralova Lesna, Ivana .
VACCINES, 2019, 7 (04)
[44]   Immunogenicity of Diphtheria Booster Vaccination in Adolescents With Inflammatory Bowel Disease [J].
Dembinski, Lukasz ;
Krzesiek, Elzbieta ;
Klincewicz, Beata ;
Grzybowska-Chlebowczyk, Urszula ;
Demkow, Urszula ;
Banaszkiewicz, Aleksandra ;
Radzikowski, Andrzej .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2020, 39 (03) :244-246
[45]   Reduced immunogenicity of diphtheria and tetanus toxoids when combined with pertussis toxoid [J].
Trollfors, B ;
Taranger, J ;
Lagergård, T ;
Sundh, V .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (01) :85-86
[46]   Dot immunoassay for the simultaneous determination of postvaccination immunity against pertussis, diphtheria, and tetanus [J].
Khramtsov, Pavel ;
Bochkova, Maria ;
Timganova, Valeria ;
Zamorina, Svetlana ;
Rayev, Mikhail .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2017, 409 (15) :3831-3842
[47]   Patient attitudes toward influenza and tetanus, diphtheria and acellular pertussis vaccination in pregnancy [J].
Strassberg, Emmie R. ;
Power, Michael ;
Schulkin, Jay ;
Stark, Lauren M. ;
Mackeen, A. Dhanya ;
Murtough, Katie L. ;
Paglia, Michael J. .
VACCINE, 2018, 36 (30) :4548-4554
[48]   Immunity to diphtheria and tetanus among blood donors in Arak, central province of Iran [J].
Eslamifar, Ali ;
Ramezani, Amitis ;
Banifazl, Mohammad ;
Sofian, Masoomeh ;
Mandaviani, Fatemeh-Alsadat ;
Yaghmaie, Farhad ;
Aghakhani, Arezoo .
IRANIAN JOURNAL OF MICROBIOLOGY, 2014, 6 (03) :190-193
[49]   Dot immunoassay for the simultaneous determination of postvaccination immunity against pertussis, diphtheria, and tetanus [J].
Pavel Khramtsov ;
Maria Bochkova ;
Valeria Timganova ;
Svetlana Zamorina ;
Mikhail Rayev .
Analytical and Bioanalytical Chemistry, 2017, 409 :3831-3842
[50]   A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults [J].
Booy, Robert ;
Van Der Meeren, Olivier ;
Ng, Su-Peing ;
Celzo, Froilan ;
Ramakrishnan, Gunasekaran ;
Jacquet, Jeanne-Marie .
VACCINE, 2010, 29 (01) :45-50